日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012

胸腺球蛋白在欧洲和亚洲作为再生障碍性贫血的一线治疗方案:2001-2012年治疗的955例患者的疗效

Bacigalupo, Andrea; Oneto, Rosi; Schrezenmeier, Hubert; Hochsmann, Britta; Dufour, Carlo; Kojima, Seiji; Zhu, Xiaofan; Chen, Xiaojuan; Issaragrisil, Surapol; Chuncharunee, Suporn; Jeong, Dae Chul; Giammarco, Sabrina; Van Lint, Maria Teresa; Zheng, Yizhou; Vallejo, Carlos

Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party

是否应常规向所有接受抗胸腺细胞球蛋白(ATG)免疫抑制治疗的再生障碍性贫血患者输注辐照血液制品?欧洲血液和骨髓移植组重型再生障碍性贫血工作组的一项调查

Marsh, Judith; Socie, Gerard; Tichelli, Andre; Schrezenmeier, Hubert; Hochsmann, Britta; Risitano, Antonio M; Fuehrer, Monika; Bekassy, Albert N; Korthof, Elizabeth T; Locasciulli, Anna; Ljungman, Per; Bacigalupo, Andrea; Camitta, Bruce; Young, Neal S; Passweg, Jakob